S. 1157

119 S1157 ES: Women and Lung Cancer Research and Preventive Services Act of 2025
 U.S. Senate
 text/xml
 EN
 Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
 119th CONGRESS  2d Session  S. 1157  IN THE SENATE OF THE UNITED STATES  AN ACT
To direct the Secretary of Health and Human Services to conduct a review to evaluate the status of research on lung cancer in women and underserved populations, and for other purposes.
1.
Short title
This Act may be cited as the   Women and Lung Cancer Research and Preventive Services Act of 2025  .
2.
Interagency review to evaluate and identify opportunities to improve lung cancer prevention and treatment in women
(a)
In general
The Secretary of Health and Human Services, in consultation with the Secretary of Defense and the Secretary of Veterans Affairs, shall review and, as necessary and appropriate, update Federal programs, activities, and strategic plans related to lung cancer research, prevention, diagnosis, and treatment for purposes of—
(1)
identifying and addressing knowledge gaps and improving health outcomes related to lung cancer in women and populations with few known risk factors; and
(2)
improving lung cancer screening rates among populations recommended by the United States Preventive Services Task Force to receive such screening.
(b)
Content
The review under subsection (a) shall include—
(1)
a review of findings from research on lung cancer in populations described in paragraphs (1) and (2) of subsection (a), the status of ongoing federally funded research on lung cancer in such populations, and knowledge gaps related to lung cancer in such populations;
(2)
consideration of additional research opportunities, including through interagency collaboration and multidisciplinary projects, that would—
(A)
eliminate knowledge gaps in research on lung cancer in women, including an evaluation of any environmental and genomic factors that may be related to the etiology of lung cancer in women;
(B)
improve screening rates among populations described in subsection (a)(2); or
(C)
foster advances in technology and interventions, including biomarker testing, to improve lung cancer risk assessment, diagnosis, and treatment; and
(3)
a review of current public health strategies, and consideration of alternative evidence-based strategies, related to lung cancer screening and diagnosis, including an assessment of the need for additional public awareness and education.
(c)
Report
Not later than 2 years after the date of the enactment of this Act, the Secretary of Health and Human Services shall submit to the Committee on Health, Education, Labor, and Pensions and the Committee on Appropriations of the Senate and the Committee on Energy and Commerce and the Committee on Appropriations of the House of Representatives a report on the review conducted under subsection (a), including—
(1)
a summary of research findings, ongoing research projects, and knowledge gaps described in subsection (b)(1);
(2)
a description of any changes made by such Secretary or the head of any other Federal agency to Federal programs, activities, or strategic plans based on the findings of the review; and
(3)
any additional changes to Federal programs, activities, or strategic plans recommended by the Secretary based on the review, and any statutory or other barriers that impede implementation of such changes.
    Passed the Senate June 8, 2026.    Secretary